MIL-OSI Europe: Answer to a written question – Court of Justice of the European Union decision and the need to disclose vaccine purchase conditions – E-002641/2024(ASW)

As the Commission pointed out in its reply to Written Question E-000814/2023[1], in line with the EU Vaccines Strategy[2], the Commission and the Member States have taken a common EU approach to securing COVID-19 vaccine supplies and facilitating their distribution.

An Agreement[3] was concluded between the Commission and the Member States allowing the Commission to procure COVID-19 vaccines on behalf of the Member States and related procedures.

This Agreement established a Steering Board, where all Member States are represented, to provide guidance throughout the evaluation process, as well as a Joint Negotiation Team composed of Commission officials and Member States representatives to carry out the negotiations.

In accordance with the Agreement, individual Commissioners, including the President of the Commission, did not have any role in negotiations.

Agreements concluded by the Commission on behalf of the Member States have been signed by the Commissioner for Health and Food Safety, following a decision of the Commission as a college.

• [1] https://www.europarl.europa.eu/doceo/document/E-9-2023-000814-ASW_EN.html
• [2] https://eur-lex.europa.eu/legal-content/EN/TXT/PDF/?uri=CELEX:52020DC0245
• [3]  COM(2020)4192 final: https://commission.europa.eu/publications/commissions-centralised-eu-approach_en